Close Menu

    Subscribe to Updates

    Get the latest creative news from Healthradar about News,Health and Gadgets.

    Bitte aktiviere JavaScript in deinem Browser, um dieses Formular fertigzustellen.
    Wird geladen
    What's Hot

    I was bored of my usual fitness apps, but comprehensive fitness tracker BetterMe dwarfs them in terms of scale

    14. Juni 2026

    Bose just went early with its Prime Day deals on Amazon — here are two I’d buy, and one that I’d avoid for now

    13. Juni 2026

    ‚Hip bridges are brilliant‘: A PT who’s trained everyone from Pedro Pascal to Margot Robbie shares his go-to exercise for staying pain-free over 30

    13. Juni 2026
    Facebook X (Twitter) Instagram
    Facebook X (Twitter) Instagram Pinterest Vimeo
    healthradar.nethealthradar.net
    • Home
    • Ai
    • Gadgets
    • Health
    • News
    • Contact Us
    Contact
    healthradar.nethealthradar.net
    Home»News»Cardiosense appoints John Martin as chief medical officer
    News

    Cardiosense appoints John Martin as chief medical officer

    HealthradarBy Healthradar13. August 2025Keine Kommentare2 Mins Read
    Share Facebook Twitter Pinterest LinkedIn Tumblr Reddit Telegram Email
    Cardiosense appoints John Martin as chief medical officer
    Share
    Facebook Twitter LinkedIn Pinterest Email


    Name: John Martin

    New title: Chief medical officer, Cardiosense

    Previous title: Chief medical officer emeritus, Butterfly Network

    Cardiosense has appointed John Martin as chief medical officer. The appointment puts Martin in charge of clinical development and product strategy as the company prepares for commercial launch.

    Chicago-based Cardiosense recently received Food and Drug Administration clearance for its wearable heart monitor, CardioTag. The company is developing AI models that use data captured by the monitor, for example to estimate pulmonary capillary wedge pressure in heart failure patients. Cardiosense is now working to validate its cardiac filling pressure algorithm and prepare a regulatory filing for the AI tool. 

    Amit Gupta, Cardiosense co-founder and CEO, said in a statement that Martin’s combination of clinical expertise and medtech leadership will benefit the company as it tries to bring the algorithm to market. 

    Martin, a practicing vascular surgeon, joins Cardiosense from point-of-care ultrasound company Butterfly Network. Butterfly works across medical specialties but cardiology is a focus area. At Butterfly, Martin was involved in work including a collaboration with the American College of Cardiology and research into the use of machine learning and handheld ultrasound devices to screen for aortic stenosis.

    At Cardiosense, Martin will build on initiatives such as a clinical trial that found CardioTag and an AI algorithm can estimate PCWP with an accuracy approaching that of implantable hemodynamic sensors. The company is focusing on PCWP in the belief the metric can provide an early indication of the deterioration of heart failure patients.

    If authorized by the FDA, the algorithm paired with CardioTag could offer an alternative to Abbott’s Cardiomems implant. Cardiomems monitors another sign of worsening heart failure. Cardiosense has identified procedural risk, patient burden and low penetration among eligible heart failure populations as limitations of implantable monitors that it is aiming to overcome with its products.



    Source link

    appoints Cardiosense Chief John Martin Medical officer
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    Previous ArticleMarchex Unveils AI Healthcare Solution to Transform Patient Acquisition and Marketing
    Next Article Medicare Part D premiums are likely to go up next year. Here’s why.
    ekass777x
    Healthradar
    • Website

    Related Posts

    News

    The90 Launches $299 UV-Tracking Smart Jewelry with Backing from Lauryn Bosstic

    13. Juni 2026
    News

    Louisiana Department of Health Partners with Phenomune to Launch Free Statewide At-Home Immune Profiling

    13. Juni 2026
    News

    Penumbra’s FDA nod for clot removal tech a win for Boston Scientific

    13. Juni 2026
    Add A Comment
    Leave A Reply Cancel Reply

    Top Posts

    Marvel’s Dyasonic: A Superhero Powered by Sound—and Diabetes Tech

    13. Juni 2025356 Views

    Tombot Secures $6.1M to Bring Lifelike Robotic Puppy to Seniors with Dementia –

    19. Juni 2025306 Views

    Luna ring review | TechRadar

    26. Dezember 2025148 Views

    Serena-backed health tech lands first FDA approval for home cervical cancer test

    31. Mai 2025141 Views
    Stay In Touch
    • Facebook
    • YouTube
    • TikTok
    • WhatsApp
    • Twitter
    • Instagram
    Latest Reviews

    Subscribe to Updates

    Bitte aktiviere JavaScript in deinem Browser, um dieses Formular fertigzustellen.
    Wird geladen
    About Us

    Welcome to HealthRadar.net — your trusted destination for discovering the latest innovations in digital health. We are dedicated to connecting individuals, healthcare professionals, and organizations with cutting-edge tools, applications

    Most Popular

    Marvel’s Dyasonic: A Superhero Powered by Sound—and Diabetes Tech

    13. Juni 2025356 Views

    Tombot Secures $6.1M to Bring Lifelike Robotic Puppy to Seniors with Dementia –

    19. Juni 2025306 Views
    USEFULL LINK
    • About Us
    • Contact Us
    • Disclaimer
    • Privacy Policy
    QUICK LINKS
    • Ai
    • Gadgets
    • Health
    • News
    • About Us
    • Contact Us
    • Disclaimer
    • Privacy Policy
    Copyright© 2025 Healthradar All Rights Reserved.

    Type above and press Enter to search. Press Esc to cancel.